Julian Adams jumps ship from a deeply troubled Infinity Pharma
Julian Adams, the R&D chief of Infinity Pharmaceuticals $INFI for the past 14 years and a prominent face for one of the most high-profile biotechs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
